Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15957)

• Formulation Name: Ondansetron 4 mg tablet
• Company: GlaxoSmithKline; Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Aspartame	(E00402)	134601	Flavoring agent
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Propylparaben sodium	(E00567)	23679044	Antimicrobial preservative
Sodium methylparaben	(E00543)	23663626	Antimicrobial preservative